| mRNA |
chlorambucil |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.9 |
| mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.007 |
0.9 |
| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.0054 |
0.9 |
| mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
0.0064 |
0.9 |
| mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
0.053 |
0.9 |
| mRNA |
BRD-K64610608 |
CTRPv2 |
pan-cancer |
AAC |
-0.0073 |
0.9 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0058 |
0.9 |
| mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
-0.0086 |
0.9 |
| mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
-0.0056 |
0.9 |
| mRNA |
GSK2636771 |
CTRPv2 |
pan-cancer |
AAC |
-0.0079 |
0.9 |